Brief: Evolent Health Q3 Revenue USD 621.401 Million Vs. IBES Estimate USD 627.2 Million
07/11/2024 21:10
Nov 07 (Reuters) - Evolent Health Q3 adjusted EBITDA USD 31.801 million vs. IBES estimate USD 62.7 million. * Q3 adjusted EBITDA margin 5.1% * Q3 net income USD -31.231 million vs. IBES estimate USD 40.6 million * outlook FY adjusted EBITDA USD 160-175 million * outlook Q4 adjusted EBITDA USD 22-37 million
Recent news on Evolent Health
See all newsEvolent Health, Inc. reports results for the quarter ended June 30 - Earnings Summary
Evolent Health Q2 revenue beats expectations
Brief: Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million
Evolent Health, Inc. expected to post a loss of 2 cents a share - Earnings Preview
Evolent Health Q1 revenue misses estimates as margin narrows